Research on a mouse NAFLD model has demonstrated that antagonism of PPARβ/δ may regulate VLDLR and influence the serum triglyceride level and progression of NAFLD [125]. Here, PPARD is linked to metabolic dysfunction-associated steatotic liver disease.